Cleanliness is non-negotiable
Reading down the highest actual evidence column, a pattern is unmistakable: the confident, systemic, human-benefit language of the marketing is nowhere matched by the evidence tier, which is cosmetic-topical at best and rodent-preclinical at worst, and altogether absent for the blend
Five years after treatment or remission is used as a conservative review window rather than a proven biological cutoff
In research terms, this can influence: IGF-1R pathway availability binding protein competition receptor signalling duration cell culture assay interpretation growth factor marker panels myogenic marker response protein synthesis pathway research cell proliferation marker studies This is why IGF-1 LR3 is often described as a modified growth factor peptide with reduced IGFBP interaction
This suggests that glutathione might protect against age-related diseases including cancer, diabetes, and arthritis, which have been linked to high levels of oxidative stress
Devices to overcome the buccal mucosal barrier to administer therapeutic peptides
